Influenza virus infections transiently suppress pulmonary antibacterial defenses by causing dysfunctions in the alveolar macrophage phagocytic system (6, 29) . The growth of virus in the lungs is not immediately accompanied by the impairment of phagocyte function. Instead, the macrophage defect is associated with the period of time of rapidly declining pulmonary virus titers and the concomitant development of the antiviral immune response in the lungs (9, 13) . This temporal relationship suggests that alveolar macrophage dysfunction does not result from a direct effect of virus on phagocytes (19) and that the host immune response may play a role in the defect (11) . Indeed, recently we have demonstrated that the transient defect in alveolar macrophage phagocytosis is, in part, mediated by the humoral (10) and cell-mediated (13) antiviral immune response of the host.
Formation of immune complexes is a normal immunological response to viral antigens (20) , and immune complexes have been shown to induce phagocytic defects in macrophages (7, 17) and polymorphonuclear leukocytes (26) . However; to produce the defect, the immune complexes have to be at or near their equivalence, since small soluble complexes found in antigen or antibody excess are generally innocuous to normal phagocytic function (26) . Herein, we tested the hypotheses that immune complexes are formed in the lungs during the course of influenza virus infection and that the immune complexes are at the greatest detectable concentration during the time of maximal virus-induced suppression of alveolar macrophage phagocytosis. We also demonstrated that incubation of these immune complexes with normal alveolar macrophages suppresses phagocytosis.
MATERIALS AND METHODS Animals. Female Swiss mice (Harlan Sprague-Dawley, Walkersville, Md.) weighing between 20 and 25 g were used in this study. The animals were fed rat chow and water ad libitum. Infected and uninfected animals were housed in separate rooms to prevent cross contamination. Viral infections. Influenza A/PR8/34 virus was grown and titrated in the allantoic fluid of 10-day-old embryonated chicken eggs by standard methods (15) . The virus had a titer of 107-5 median egg infectious doses per ml and was stored in small portions at -80°C. Mice were infected by a 30-min aerosol inhalation of a 1:50 dilution of the virus as previously described (12) . The resultant infection induced a moderate to severe pneumonia that was sublethal to the animals.
Pulmonary lavage. On days 3, 7, 10, 15, and 30 after the onset of viral infection, infected and noninfected mice were sacrificed by cervical dislocation and exsanguinated by cardiac puncture. Serum was separated and stored at -20°C. The lungs were surgically removed and lavaged with three 1.5-ml portions of fluid as described previously (1) . After centrifugation (200 x g for 10 min) lavaged cells from normal mice were suspended in Hanks balanced salt solution and counted in a hemacytometer. A portion of the collected alveolar lavage fluid was stored at -80°C for later analysis for viral antigen and antiviral antibody by immunoassay. The remaining portion of the lavage fluid was mixed with equal volumes of 12% polyethylene glycol (PEG; Sigma Chemical Co., St. Louis, Mo.) in borate buffer (pH 5.8), and the mixture was left overnight at 4°C to precipitate immune complexes. This 6% PEG solution caused the precipitation of large-molecular-weight immune complexes, but it exclud-ed monomeric immunoglobulin G (IgG) (4) . Although PEG precipitation of immune complexes from bronchoalveolar lavage fluid has not been documented, this method has been applied to precipitate immune complexes from synovial fluid (16 (32) .
(ii) Antibody detection. Microtiter wells were precoated with chicken antibody against influenza A/PR8/34 and then incubated with the egg-grown stock virus (diluted 1:50 in PBS-Tween) for 2 h at 37°C. Each well was rinsed three times with PBS-Tween to remove excess virus. Three dilutions from each lavage supernatant fluid were incubated in separate wells for 1 h at 37°C. After the microtiter wells were washed three times with PBS-Tween, a 100 RI sample of alkaline phosphatase-labeled goat antibody against mouse IgG was added for 1 h at 37°C. The wells were rinsed and incubated with 100 RI of p-nitrophenyl phosphate for 30 min at 37°C. The resultant relative absorbances at 405 nm were used to calculate the specific antibody titer against influenza virus by extrapolating to the dilution at which the relative absorbance was no longer greater than 2 standard deviations above that of lavage fluid from noninfected control animals.
(iii) Immune complex detection. Immune complexes in the lavage fluid and serum of virus-infected mice were quantified by methods previously described (31) . Briefly, raw bovine semen (generously donated by Sire Power, Frederick, Md.) was stored in small portions at -20°C. Before each assay, the semen was washed three times with PBS; the spermatozoa were counted with a hemacytometer and suspended to 107 spermatozoa per ml in PBS. A 100-pl sample of the spermatozoan suspension was added to each well of a polyvinyl microtiter plate, which was then centrifuged (1, 000 x g for 10 min) and submerged in a 0.25% glutaraldehyde-PBS solution for 5 min. The plate was inverted and snapped to remove the fixative and then rinsed three times with PBSTween. A 50-pA sample of lavage fluid or serum, diluted with an equal volume of PBS-Tween, was added to each spermcoated well, and the wells were incubated at 37°C for 2 h. After each well was rinsed three times with PBS-Tween, 100 pul of alkaline phosphatase-labeled goat antibody to mouse IgG (diluted 1:400 with PBS-Tween) was added, and the wells were incubated at 37°C for 1 h. The microtiter wells were rinsed three times with PBS-Tween, and a 100-pA sample of p-nitrophenyl phosphate substrate solution was incubated in each well for 30 min at 37°C. The relative absorbance at 405 nm was used to measure the concentration of immune complexes. For a more complete quantitation of immune complexes, mouse IgG was heat aggregated at 63°C for 20 min and then separated from monomeric immunoglobulin by precipitation in 6% PEG (molecular weight, 8000). The precipitated aggregates of IgG have properties similar to those described for antigen-antibody complexes (21, 22 (31) , the data in Fig. 1 were used in making a standard curve to quantitate complexes in the lungs of virus-infected mice.
The temporal relationship among the concentrations of viral antigen, antiviral IgG, and immune complexes in the acellular lung lavage fluid during the course of influenza virus infection is presented in Fig. 2 . The high concentrations of influenza virus antigen that existed during the early stages of infection (day 3) rapidly declined to undetectable levels by day 10. In contrast, antiviral IgG was only detected at low concentrations during week 1 of infection. However, after day 7, the antibody levels continued to rapidly increase To determine what effect the presence of virus-induced immune complexes have on pulmonary phagocytic function, normal alveolar macrophages were preincubated with immune complexes isolated from lung lavage fluids of virusinfected mice and challenged with opsonized SRBCs as the phagocytic particle (Fig. 3) . Preliminary assays were performed with lung lavage fluid directly incubated with normal macrophages, and a slight inhibition of phagocytosis was observed. By using PEG precipitation techniques on lung lavage fluid, the large dilution factor inherent to lavage techniques was circumvented, which allowed the concentration of immune complexes. After concentration, a doseresponse relationship of phagocytosis inhibition could still be demonstrated (Fig. 3, insert) , consistent with the previously described properties of immune complexes (7) . Although we did not directly establish that the parameters of the PEG precipitation techniques are the same for both serum and lung lavage fluid, our experimental results are consistent with the fact that a surfactant did not alter the precipitation of immune complexes from lavage fluid. Antibody-mediated phagocytosis of SRBCs was depressed by 68 ± 7% in the presence of immune complexes from day 10 virus-infected animals-twice the percent depression caused by immune complexes from virus-infected mice on other days. The inhibitory properties of day 10 immune complexes were dose dependent between 0.01 and 15 ,ug of protein ( 3, insert), causing phagocytosis impairment of up to 75%. Microscopic observation showed that over 90% of all macrophages (including controls) remained phagocytic during these assays. Therefore, a major suppressive effect of immune complexes from virus-infected mice appears to be a decrease in the number of engulfed SRBCs per macrophage.
To test whether virus-induced immune complexes interfered with antibody-independent phagocytosis, alveolar macrophage monolayers were challenged with unopsonized C. krusei. In the presence of immune complexes lavaged from infected mice, antibody-independent phagocytosis was not significantly altered (Fig. 4) . In contrast, immune complexes did interfere with the ingestion of specifically opsonized C. krusei (Fig. 4) . In fact, immune complexes from day 10 virus-infected mice depressed macrophage ingestion of antibody-coated yeast cells by 41%. As in the erythrocyte assays, immune complexes did not significantly change the number of phagocytic macrophages (Fig. 4) ; therefore, the defect in the phagocytic index reflects only a decrease in the number of yeast cells ingested per phagocyte.
DISCUSSION
As a consequence of influenza virus infection, there exists a transient impairment of alveolar macrophage phagocytic activity (28) . Previous studies in our laboratory have demonstrated a failure of Fc receptor-mediated ingestion by alveolar macrophages that occurred ca. 9 days after the onset of virus infection in mice (28) . Concomitantly, Fc receptor binding activity remained normal, and cytophilic Fc and complement receptor activities were enhanced, thus suggesting that the virus-induced defect was not a generalized metabolic dysfunction but a receptor-specific phenomenon. The observed suppression of phagocytosis occurs predominantly during week 2 of the viral infection (11) in animals with intact humoral (10) and cellular immune (13) responses. Since the infectious state of the virus infection is virtually resolved after week 1 (30) , it seems likely that the virus acts indirectly to produce its adverse effects on phagocytosis.
The present study tested the hypothesis that immune complex formation, known to cause dysfunction in macrophage and neutrophil phagocytic function in vitro (7), may be one mechanism by which influenza virus interferes with phagocyte function.
There are numerous assays by which immune complexes can be measured (14) . Most established methods bind complexes via Fc receptors (18) or complement receptors (8) . Similarly, bovine spermatozoa have Fc receptors that bind predominantly complexed antibody and not monomeric antibody (31) . We have demonstrated ( Fig. 1 and 2 ) not only that this immune complex assay was quantitatively sensitive to various concentrations of immune complex-like A-IgG, but also that it was not affected by the accumulated levels of monomeric IgG that existed at day 30 after virus infection. However, like other assays, bovine spermatozoa bound any immune complex present and did not show specificity for antigen.
Using the bovine spermatozoa assay, we found that influenza virus infection induced immune complex formation (recoverable by lavage) predominantly during week 2 (Fig.  2) . This corresponded to a time when the lung fluid was changing from viral antigen excess to antiviral antibody excess as immunological defenses were becoming well established. This suggests that a previous report failed to detect immune complexes by immunofluorescence in the lungs of virus-infected mice, possibly because the experiments did not go beyond day 5 of infection (23) . Others have shown that the size, solubility, and characteristics of immune complexes are determined by the ratio of antigen to antibody (21) . Therefore, during the course of influenza virus infection, there existed a continuum of changing conditions that resulted in the formation of immune complexes of various sizes and composition. The importance of immune complex size on interaction with phagocytes has been widely reported (7, 21) . Large immune complexes, formed in vitro near the equivalence point, were much more able to impair phagocytosis (7) and to stimulate release of oxygen metabolites (26) from macrophages and neutrophils than were small immune complexes formed in antigen or antibody excess. Similarly, we have demonstrated that when the amount of detectable immune complexes in virus-infected mice was at a maximum, the ability of these complexes to impair antibody-mediated phagocytosis by macrophages was greater than at any other time (Fig. 3 and 4) .
Whether the difference in macrophage phagocytic impairment was due to immune complex size or simply to the absolute amount of immune complexes recovered is important. As we have demonstrated, inhibition of phagocytosis is dose dependent (Fig. 3, insert) . However, immune complex concentrations from day 7 virus-infected mice were almost equal to those from day 10 animals, yet day 7 immune complexes had only a small inhibitory action against phagocytosis. This, most likely, is due to the fact that since the bovine spermatozoa assay cannot differentiate between a few large immune complexes and many smaller immune complexes, two samples that are approximately equal by this detection assay may indeed contain different sizes of immune complexes and consequently affect macrophage function differently.
Not all phagocytic functions of macrophages were affected by immune complexes. Ingestion of C. krusei yeast cells is mediated through mannose-type receptors (27) and is not altered significantly by immune complexes (Fig. 4) . From this and previous reports (7), it appears that only antibodymediated phagocytosis is paralyzed in the presence of immune complexes and that the consequences of this transient phenomenon in virus-infected animals may be limited in scope. However, when a phagocytic particle that can be phagocytized via alternate receptors is coated with antibody, immune complexes inhibit its ingestion (Fig. 4) . Therefore, antibody-mediated phagocytosis becomes dominant, possibly because the antibody molecule protrudes away from the particle. This predominance in specific receptors may mean that in the lungs of virus-infected mice, particles or opportunistic microorganisms are protected from ingestion by opsonizing antibody.
This study documents the formation of immune complexes in influenza virus-infected mice and demonstrates macrophage dysfunction caused by immune complexes isolated from these mice.
